Monday, April 29, 2019
(Ethics and Communication) Illinois among states to settle with Article
(Ethics and Communication) Illinois among states to settle with GlaxoSmithKline - Article ensampleAlthough the two main ingredients Kytril and Bactroban were not fully contaminated, the tablets possessed not a full dose of an mobile ingredient which did not satisfy the appropriate percentage of the substance listed in the bottle. Although the company denied of fraud, the head lawyer confirmed that the accusation was legit and the attempt to earn revenue through illegal practices were exercised. Without a doubt, this article render the controversy related to a company who was charged of fraud because of varied content of substance in their capsules. Although the company has an excellent reputation for following compliances implemented by the government these type of instances should still be taken into account. Ethically speaking, the company should have made some attempt to at least communicate with the FDA to discuss the gravity of this situation. However, the company instead is denying the charges that it made to benefit itself in the long-run. Clearly, this type of hostile office does not only poses a risk for corporate ethics it also serves as a reminder of these type of scenarios can be detrimental to society itself. Corporations must make it their obligation to take righteousness in any sort of moral dilemmas so they lives of many can be saved.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.